Adherence with statin therapy in secondary, prevention of coronary heart disease in veterans administration male population

被引：61

作者：

Kopjar, B

Sales, AEB

Piñeros, SL

Sun, H

Li, YF

Hedeen, AN

机构：

[1] Univ Washington, Hlth Sci Ctr H68, Dept Hlth Serv, Seattle, WA 98195 USA

[2] Vet Adm Puget Sound Hlth Care Syst, Hlth Serv Res & Dev Ctr Excellence, Seattle, WA USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 09期

关键词：

D O I：

10.1016/j.amjcard.2003.07.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This retrospective cohort study enrolled 8,768 male Veterans Administration patients with coronary heart disease who were prescribed statins from July 1, 1999, to June 30, 2000. After 18 months of follow-up, 71% of the patients had been dispensed greater than or equal to80% of the medication. Our population's persistence in using statins was higher than in other open-population cohorts but lower than in randomized controlled trials. (C) 2003 by Excerpta Medica, Inc.

引用

页码：1106 / 1108

页数：3

共 50 条

[1] Closing Gaps in Lifestyle Adherence for Secondary Prevention of Coronary Heart Disease
Aggarwal, Monica
Ornish, Dean
Josephson, Richard
Brown, Todd M.
Ostfeld, Robert J.
Gordon, Neil
Madan, Shivank
Allen, Kathleen
Khetan, Aditya
Mahmoud, Ahmed
Freeman, Andrew M.
Aspry, Karen
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2021, 145 : 1 - 11
[2] EXAMINING MEDICATION ADHERENCE AMONG TRICARE BENEFICIARIES RECEIVING STATIN THERAPY FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MILITARY TREATMENT FACILITIES IN THE UNITED STATES
Nwokeji, E.
Yarger, S.
Trice, S.
Chao, S.
Devine, J.
Potyk, R.
Gutke, G.
Bonnema, A.
[J]. VALUE IN HEALTH, 2011, 14 (03) : A44 - A44
[3] Secondary prevention of coronary heart disease at population level in Poland
Broda, G.
Kurjata, P.
Piwonska, A.
Polakowska, M.
Piwonski, J.
[J]. EUROPEAN HEART JOURNAL, 2006, 27 : 301 - 302
[4] Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Zhu, Lijun
Fang, Yangliang
Gao, Beibei
Jin, Xiangbo
Zheng, Jiamin
He, Ying
Huang, Jinyu
[J]. BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
[5] Hormone replacement therapy for secondary prevention of coronary heart disease
Ong, PJL
Sorensen, MB
Hayward, CS
Webb, CM
Collins, P
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (09): : 794 - 795
[6] Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan
Shau, Wen-Yi
Lai, Chao-Lun
Huang, Shih-Ting
Chen, Shu-Ting
Li, Jim Z.
Fung, Selwyn
Tse, Vicki C.
Lai, Mei-Shu
[J]. HEART ASIA, 2019, 11 (02)
[7] Global risk, statin eligibility and secondary coronary heart disease prevention in hypertensive patients
Pedrinelli, R
Omo, GD
Buda, S
Esposti, ED
Mariani, M
[J]. JOURNAL OF HYPERTENSION, 2003, 21 : S281 - S282
[8] Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials
Mega, Jessica L.
Stitziel, Nathan O.
Smith, J. Gustav
Chasman, Daniel I.
Caulfield, Mark J.
Devlin, James J.
Nordio, Francesco
Hyde, Craig L.
Cannon, Christopher P.
Sacks, Frank M.
Poulter, Neil R.
Sever, Peter S.
Ridker, Paul M.
Braunwald, Eugene
Melander, Olle
Kathiresan, Sekar
Sabatine, Marc S.
[J]. LANCET, 2015, 385 (9984): : 2264 - 2271
[9] Correction: Effect of an increase in Lp(a) following statin therapy on cardiovascular prognosis in secondary prevention population of coronary artery disease
Lijun Zhu
Yangliang Fang
Beibei Gao
Xiangbo Jin
Jiamin Zheng
Ying He
Jinyu Huang
[J]. BMC Cardiovascular Disorders, 22
[10] Secondary prevention in coronary heart disease
Haq, IU
Minnis, RC
Jackson, PR
Yeo, WW
Ramsay, LE
[J]. JOURNAL OF HUMAN NUTRITION AND DIETETICS, 1996, 9 (05) : 363 - 371

← 1 2 3 4 5 →